trial · primary record
Biospecimen Collection
Childhood Malignant Solid Neoplasm
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 20 |
| Primary completion | 2027-05-01 |
| Primary endpoint | Accuracy of Cytalux™ (pafolacianine) injection used with NIR fluorescent imaging for detecting lesions |
| Registry ID | NCT06915727 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:45:15.997Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06915727
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Biospecimen Collection · compound